Mirum Pharmaceuticals MIRM
$96.13 +$0.62 (+0.65%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $96.13 0.00%
Open$94.50
Prev close$95.51
Day range$94.10 – $98.39
Volume1.06M
Market cap$6.28B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$185.72M+39.6% YoY
Operating profit-$46.25M-1,876.6% YoY
Net profit-$40.77M-1,503.3% YoY
Diluted EPS-$0.87-1,840.0% YoY
Free cash flow-$5.62M-114.2% YoY
Operating cash flow-$4.31M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin81.7%
Operating margin-21.6%
Net margin-134.8%
Return on equity-760.0%
Return on assets-99.8%
Return on invested capital-139.4%
Current ratio2.07
Liabilities / assets105.3%
Cash & investments$373.69M
Total debt$740.97M
Net cash (debt)-$367.28M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $185.72M | $176.24M | $159.88M | $521.31M | $148.93M |
| Total Operating Revenue | $185.72M | $176.24M | $159.88M | $521.31M | $148.93M |
| Cost of Revenue | $35.17M | $30.35M | $28.81M | $100.24M | $28.26M |
| Gross Profit | $150.55M | $145.90M | $131.08M | $421.07M | $120.67M |
| Operating Expense | $196.80M | $172.00M | $194.24M | $443.21M | $130.24M |
| Selling and Admin Expenses | $88.86M | $81.47M | $96.33M | $257.03M | $74.13M |
| Research & Development | $107.93M | $90.53M | $97.91M | $186.18M | $56.11M |
| Operating Profit | -$46.25M | -$26.10M | -$63.16M | -$22.14M | -$9.57M |
| Net Non-Operating Interest Income (Expense) | $3.08M | $1.23M | -$215,000.00 | -$1.66M | -$178,000.00 |
| Non-Operating Interest Income | $4.69M | $3.85M | $3.40M | $12.73M | $3.42M |
| Non-Operating Interest Expense | $1.61M | $2.62M | $3.62M | $14.39M | $3.60M |
| Other Income (Expense) | $2.94M | -$40.67M | -$726.30M | $2.37M | $4.78M |
| Special Income (Charges) | -$13.50M | -$16.44M | -$726.30M | $0.00 | $5.00M |
| -Less:Other Special Charges | $13.50M | $16.44M | $726.30M | – | – |
| Other Non-Operating Income (Expenses) | $16.44M | -$24.23M | – | $2.37M | -$218,000.00 |
| Pretax Profit | -$40.23M | -$65.54M | -$789.68M | -$21.43M | -$4.96M |
| Tax | $538,000.00 | $1.69M | $475,000.00 | $1.94M | $767,000.00 |
| Net Profit | -$40.77M | -$67.23M | -$790.16M | -$23.36M | -$5.73M |
| Profit from Continuing Operations | -$40.77M | -$67.23M | -$790.16M | -$23.36M | -$5.73M |
| Net Income to Parent Company | -$40.77M | -$67.23M | -$790.16M | -$23.36M | -$5.73M |
| Net Income to Common Stockholders | -$40.77M | -$67.23M | -$790.16M | -$23.36M | -$5.73M |
| Basic EPS | -$0.62 | -$1.06 | -$13.43 | -$0.47 | -$0.11 |
| Diluted EPS | -$0.87 | -$1.06 | -$13.43 | -$0.47 | -$0.11 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.03B | $1.04B | $890.92M | $842.81M | $842.81M |
| Total Current Assets | $586.63M | $636.31M | $569.44M | $549.68M | $549.68M |
| Cash and Cash Equivalents & Short-Term Investments | $373.69M | $438.29M | $386.26M | $383.33M | $383.33M |
| -Cash and Cash Equivalents | $243.19M | $330.73M | $324.91M | $296.68M | $296.68M |
| -Short Term Investments | $130.50M | $107.56M | $61.35M | $86.64M | $86.64M |
| Receivables | $156.35M | $145.36M | $133.11M | $123.33M | $123.33M |
| -Accounts Receivable | $156.35M | $145.36M | $133.11M | $123.33M | $123.33M |
| Inventory | $25.49M | $25.77M | $25.52M | $24.89M | $24.89M |
| Other Current Assets | $31.11M | $26.89M | $24.55M | $18.14M | $18.14M |
| Total Non-Current Assets | $439.98M | $408.67M | $321.48M | $293.13M | $293.13M |
| Net PPE | $14.61M | $14.28M | $15.06M | $10.60M | $10.60M |
| -Gross PPE | $14.61M | $14.28M | $15.06M | $10.60M | $10.60M |
| Investments and Advances | $126.77M | $123.03M | $34.35M | $8.11M | $8.11M |
| Goodwill and Other Intangible Assets | $275.65M | $247.39M | $254.15M | $260.92M | $260.92M |
| -Other Intangible Assets | $275.65M | $247.39M | $254.15M | $260.92M | $260.92M |
| Other Non-Current Assets | $22.96M | $23.98M | $17.91M | $13.50M | $13.50M |
| Total Liabilities | $1.08B | $1.06B | $648.42M | $528.12M | $528.12M |
| Total Current Liabilities | $283.08M | $222.79M | $272.82M | $205.80M | $205.80M |
| Payables | $33.83M | $39.63M | $74.62M | $25.82M | $25.82M |
| -Accounts Payable | $13.65M | $23.43M | $59.40M | $9.61M | $9.61M |
| -Other Payable | $20.18M | $16.20M | $15.22M | $16.21M | $16.21M |
| Current Accrued Expenses | $181.33M | $127.56M | $134.62M | $130.56M | $130.56M |
| Short-Term Debt and Capital Lease Obligation | $2.60M | $2.41M | $2.35M | $2.14M | $2.14M |
| -Current Capital Lease Obligation | $2.60M | $2.41M | $2.35M | $2.14M | $2.14M |
| Other Current Liabilities | $24.80M | $24.80M | $25.80M | – | – |
| Total Non-Current Liabilities | $797.72M | $832.62M | $375.60M | $322.32M | $322.32M |
| Long Term Debt and Capital Lease Obligation | $740.97M | $760.54M | $321.43M | $317.31M | $317.31M |
| -Long Term Debt | $731.25M | $750.08M | $310.25M | $309.80M | $309.80M |
| -Long Term Capital Lease Obligation | $9.72M | $10.47M | $11.18M | $7.52M | $7.52M |
| Other Non-Current Liabilities | $56.75M | $72.07M | $54.17M | $5.01M | $5.01M |
| Total Equity | -$54.19M | -$10.42M | $242.49M | $314.69M | $314.69M |
| Stockholders' Equity | -$54.19M | -$10.42M | $242.49M | $314.69M | $314.69M |
| Capital Stock | $7,000.00 | $6,000.00 | $6,000.00 | $5,000.00 | $5,000.00 |
| -Common Stock | $7,000.00 | $6,000.00 | $6,000.00 | $5,000.00 | $5,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.51B | $1.52B | $1.70B | $981.88M | $981.88M |
| Retained Earnings | -$1.57B | -$1.52B | -$1.46B | -$667.54M | -$667.54M |
| Gains/Losses Not Affecting Retained Earnings | -$2.06M | -$674,000.00 | -$28,000.00 | $351,000.00 | $351,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$4.31M | -$44.25M | -$228.76M | $55.83M | $6.07M |
| Net cash flow from continuing operations | -$4.31M | -$44.25M | -$228.76M | $55.83M | $6.07M |
| Net Income from Continuing Operations | -$40.77M | -$67.23M | -$790.16M | -$23.36M | -$5.73M |
| Gain/Loss from Continuing Operations | -$170,000.00 | $896,000.00 | $1.10M | -$1.72M | $193,000.00 |
| Depreciation & Depletion & Amortization | $6.89M | $6.94M | $6.87M | $24.24M | $6.07M |
| Other Non-Cash Items | -$15.35M | $24.79M | -$272,000.00 | $2.07M | $511,000.00 |
| Change in Working Capital | $10.97M | -$40.22M | $102.22M | -$19.72M | -$14.01M |
| -Change in Receivables | -$13.06M | -$13.74M | -$12.89M | -$48.06M | -$19.01M |
| -Change in Inventory | -$889,000.00 | $395,000.00 | -$1.92M | -$8.45M | -$2.28M |
| -Change in Prepaid Assets | -$4.31M | -$1.08M | -$6.63M | -$5.76M | $5.99M |
| -Change in Payables and Accrued Expense | $29.19M | -$19.06M | $57.24M | $50.10M | $3.44M |
| -Change in Other Current Assets | $546,000.00 | -$5.84M | -$4.80M | -$5.66M | -$1.64M |
| -Change in Other Current Liabilities | -$507,000.00 | -$891,000.00 | $71.21M | -$1.90M | -$513,000.00 |
| Net cash flow from investing | -$28.87M | -$159.99M | -$11.57M | -$23.95M | $1.01M |
| Net Cash Flow from Continuing Investing Activities | -$28.87M | -$159.99M | -$11.57M | -$23.95M | $1.01M |
| Net PPE Purchase and Sale | -$1.31M | -$23,000.00 | -$664,000.00 | -$954,000.00 | -$600,000.00 |
| Net Intangibles Purchase and Sale | $0.00 | -$25.00M | -$10.00M | $0.00 | $0.00 |
| Net Investment Purchase and Sale | -$27.56M | -$134.97M | -$905,000.00 | -$23.00M | $1.61M |
| Financing Cash Flow | -$54.34M | $211.44M | $270.08M | $40.14M | $9.00M |
| Net Cash Flow from Continuing Financing Activities | -$54.34M | $211.44M | $270.08M | $40.14M | $9.00M |
| Net Issuance Payments Of Debt | -$62.10M | – | – | $0.00 | $0.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | $259.95M | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $7.76M | $13.37M | $10.13M | $40.14M | $9.00M |
| Ending Cash Balance | $244.92M | $332.46M | $326.64M | $298.17M | $298.17M |
| Net Change in Cash | -$87.52M | $7.20M | $29.75M | $72.02M | $16.07M |
| Beginning Cash Balance | $332.46M | $326.64M | $298.17M | $222.93M | $282.50M |
| Effect of Exchange Rate Changes | -$17,000.00 | -$1.37M | -$1.27M | $3.22M | -$408,000.00 |
| Free Cash Flow | -$5.62M | -$69.28M | -$239.43M | $54.87M | $5.47M |
| Net Business Purchase and Sale | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on MIRM.
Sign in to join the discussion.